tiprankstipranks
Trending News
More News >
Johnson & Johnson’s Promising TAR-200 Platform Drives Buy Rating Amid Strong Bladder Cancer Treatment Data and Market Potential
PremiumRatingsJohnson & Johnson’s Promising TAR-200 Platform Drives Buy Rating Amid Strong Bladder Cancer Treatment Data and Market Potential
2d ago
Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting MedTech
Premium
Market News
Johnson & Johnson Stock (JNJ) Perks Up as it Mulls $2.5B Purchase of Sonic Beam Cancer Fighting MedTech
4d ago
Johnson & Johnson added to US Conviction List at Goldman Sachs
Premium
The Fly
Johnson & Johnson added to US Conviction List at Goldman Sachs
6d ago
Johnson & Johnson announces new data from Cohort 2 of Phase 2b SunRISe-1
PremiumThe FlyJohnson & Johnson announces new data from Cohort 2 of Phase 2b SunRISe-1
9d ago
Dan Loeb’s Third Point built stake in Kenvue, Financial Times reports
Premium
The Fly
Dan Loeb’s Third Point built stake in Kenvue, Financial Times reports
11d ago
China weighing exemption of some U.S. goods from tariffs, Bloomberg reports
Premium
The Fly
China weighing exemption of some U.S. goods from tariffs, Bloomberg reports
11d ago
Johnson & Johnson price target lowered to $165 from $166 at Barclays
PremiumThe FlyJohnson & Johnson price target lowered to $165 from $166 at Barclays
20d ago
Addex Therapeutics regains rights to ADX71149
Premium
The Fly
Addex Therapeutics regains rights to ADX71149
20d ago
Legend Biotech Stock (LEGN) Up on Strong Sales and Bullish Analyst Outlook
Premium
Market News
Legend Biotech Stock (LEGN) Up on Strong Sales and Bullish Analyst Outlook
20d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100